abrdn US Equity SMID Cap (S:0P0001IWHY)
30.81
+1.25
(+4.25%)
USD |
Nov 30 2025
Returns Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Key Stats
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Fixed Income Style | None |
| Broad Asset Class | None |
| Broad Category | None |
| Global Peer Group | None |
| Peer Group | None |
| Global Macro | None |
| US Macro | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Annual Total Returns Versus Peers
As of December 18, 2025.
Asset Allocation
| Type | % Net |
|---|---|
| Cash | -- |
| Stock | -- |
| Bond | -- |
| Convertible | -- |
| Preferred | -- |
| Other | -- |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Aritzia, Inc. | 3.38% | 110.25 | -2.74% |
| Boot Barn Holdings, Inc. | 3.17% | 195.31 | -3.38% |
| Wintrust Financial Corp. | 3.07% | 141.17 | 0.03% |
| e.l.f. Beauty, Inc. | 2.99% | 78.85 | 0.10% |
| Enpro, Inc. | 2.88% | 205.19 | -4.78% |
| Materion Corp. | 2.84% | 124.21 | -1.26% |
| REV Group, Inc. | 2.67% | 59.37 | -1.10% |
| Ligand Pharmaceuticals, Inc. | 2.63% | 194.53 | 0.99% |
| IDACORP, Inc. | 2.55% | 126.46 | 0.29% |
| American Healthcare REIT, Inc. | 2.53% | 47.63 | 0.02% |
Fees & Availability
| Fees | |
| Negotiable Fee | -- |
| Administrative Fee | -- |
| Maximum Management Fee | -- |
| Prospectus Custodian Fee | -- |
| Trustee Fee | -- |
| Purchase Details | |
| Open to New Investors | -- |
| Minimum Initial Investment | -- |
| Minimum Subsequent Investment | -- |
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Fixed Income Style | None |
| Broad Asset Class | None |
| Broad Category | None |
| Global Peer Group | None |
| Peer Group | None |
| Global Macro | None |
| US Macro | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Fundamentals
| General | |
| Number of Holdings | -- |
| Stock | |
| Weighted Average PE Ratio | -- |
| Weighted Average Price to Sales Ratio | -- |
| Weighted Average Price to Book Ratio | -- |
| Weighted Median ROE | -- |
| Weighted Median ROA | -- |
| Number of Equity Holdings | -- |
Fund Details
| Key Dates | |
| Inception Date | -- |
| Last Annual Report Date | -- |
| Last Prospectus Date | -- |
| Attributes | |
| Index Fund | -- |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | -- |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |